Viewing Study NCT06526247



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06526247
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-25

Brief Title: Evaluating Interventions for Intimate Partner Violence Use in Washington State
Sponsor: None
Organization: None

Study Overview

Official Title: Evaluating Interventions for Intimate Partner Violence Use in Washington State
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Intimate partner violence IPV specifically physical and psychological aggression toward an intimate partner represents a public health crisis that affects millions of Americans each year There currently exists very little evidence from randomized controlled trials for the effectiveness of abuser intervention programs designed to prevent and end perpetration of IPV in the general population This is troubling considering that approximately half a million men and women are court-mandated to these programs each year

The investigators will conduct a randomized control trial RCT investigating the efficacy of the Strength at Home SAH intervention in reducing intimate partner violence IPV The overarching aim of this study is to test the efficacy of SAH with court-involved-partner-violent men through an RCT comparing those who receive SAH with those who receive other standard IPV interventions offered in the state of Washington treatment as usual- TAU

The specific aims are

11 Compare the frequency of physical and psychological IPV the primary outcomes of interest across conditions as reported by the male participants and their intimate partners across Time 1 baseline and four 3-month follow ups Times 2-5 It is expected that greater reductions in IPV frequencies will be evidenced in SAH than TAU over the course of the year

12 Compare symptoms of PTSD alexithymia and alcohol use problems across conditions and assessment time points as reported by the male participants It is expected that greater reductions in these symptoms will be evidenced in SAH than TAU over the course of the year

13 Compare treatment satisfaction across conditions as reported by the male participants across the four 3-month follow ups Times 2-5 It is expected that treatment satisfaction will be higher in SAH than TAU
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None